CRLF2 overexpression in T-ALL has been linked to specific molecular alterations, such as mutations in PTEN, JAK3, PHF6, EZH2, and RUNX1, as well as TCF7 deletions [77]. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.